
The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on 137 anti-cancer medicines to reduce treatment costs.
Former National Health Authority CEO Indu Bhushan stated the success depends on savings reaching patients.
The revised prices are set to take effect from November 9.